Case details

Merger control

Case reference

Ccent/2017/46 - Amgen / Kirin-Amgen

Acquiring

Amgen Inc.

Description

Company active in the biotechnology sector.

Acquired

Kirin-Amgen, Inc

Description

Company active in the pharmaceutical sector.

Sector

Activity (NACE)

C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

Applicable legislation

Art. 37(1)(a) (Law 19)

Notification thresholds

Market Share threshold

Type of merger

Vertical

Cooperation with sector regulators

Status

Closed

Type of Investigation

Phase 1

AdC’s decision

Non-opposition

Case description

The notified concentration consists of the acquisition of sole control over Kirin-Amgen by Amgen

Timeline

Top links